{"title":"抗生素和吲哚美辛作为环扎术围手术期的治疗:一项系统回顾和荟萃分析","authors":"Erica Delatorre , Henrique Provinciatto , Liliam Cristine Rolo , Edward Araujo Júnior","doi":"10.1016/j.ejogrb.2024.11.036","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Prematurity complications remain the leading cause of perinatal morbidity and mortality. Although cerclage shows promise in preventing preterm birth, it remains unclear whether perioperative management, such as the use of antibiotics or indomethacin, offers any additional benefit.</div></div><div><h3>Study Desing</h3><div>We conducted a systematic review and random-effects <em>meta</em>-analysis comparing the use of indomethacin, antibiotics, and their combination as perioperative management for cerclage versus cerclage alone. Our research protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO) on June 9, 2024 (ID CRD42024552516).</div></div><div><h3>Results</h3><div>Our systematic review encompassed ten studies, and 838 pregnant women submitted to cerclage for prevention of preterm birth. We found no association between perioperative management and preterm birth before 28 weeks (RR 1.03; 95 % CI 0.76–1.39; p = 0.86), or perinatal mortality (RR 0.81; 95 % CI 0.54–1.22; p = 0.32).</div></div><div><h3>Conclusion</h3><div>Antibiotics, indomethacin, and their combination may have no additional benefit to cerclage in risk reduction of preterm birth or perinatal mortality.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"304 ","pages":"Pages 104-108"},"PeriodicalIF":1.9000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Antibiotics and indomethacin as perioperative management for cerclage: A systematic review and meta-analysis\",\"authors\":\"Erica Delatorre , Henrique Provinciatto , Liliam Cristine Rolo , Edward Araujo Júnior\",\"doi\":\"10.1016/j.ejogrb.2024.11.036\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><div>Prematurity complications remain the leading cause of perinatal morbidity and mortality. Although cerclage shows promise in preventing preterm birth, it remains unclear whether perioperative management, such as the use of antibiotics or indomethacin, offers any additional benefit.</div></div><div><h3>Study Desing</h3><div>We conducted a systematic review and random-effects <em>meta</em>-analysis comparing the use of indomethacin, antibiotics, and their combination as perioperative management for cerclage versus cerclage alone. Our research protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO) on June 9, 2024 (ID CRD42024552516).</div></div><div><h3>Results</h3><div>Our systematic review encompassed ten studies, and 838 pregnant women submitted to cerclage for prevention of preterm birth. We found no association between perioperative management and preterm birth before 28 weeks (RR 1.03; 95 % CI 0.76–1.39; p = 0.86), or perinatal mortality (RR 0.81; 95 % CI 0.54–1.22; p = 0.32).</div></div><div><h3>Conclusion</h3><div>Antibiotics, indomethacin, and their combination may have no additional benefit to cerclage in risk reduction of preterm birth or perinatal mortality.</div></div>\",\"PeriodicalId\":11975,\"journal\":{\"name\":\"European journal of obstetrics, gynecology, and reproductive biology\",\"volume\":\"304 \",\"pages\":\"Pages 104-108\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European journal of obstetrics, gynecology, and reproductive biology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0301211524006481\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/11/26 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of obstetrics, gynecology, and reproductive biology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0301211524006481","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/26 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的早产并发症仍然是围产期发病率和死亡率的主要原因。尽管环扎术显示出预防早产的希望,但尚不清楚围手术期管理,如使用抗生素或吲哚美辛,是否能提供任何额外的好处。研究设计:我们进行了一项系统综述和随机效应荟萃分析,比较了吲哚美辛、抗生素及其联合应用作为环扎术围手术期治疗与单独环扎术的疗效。我们的研究方案已于2024年6月9日在国际前瞻性系统评论登记册(PROSPERO)上注册(ID CRD42024552516)。结果本系统综述纳入10项研究,838名孕妇接受环扎术预防早产。我们发现围手术期管理与28周前早产无关联(RR 1.03;95% ci 0.76-1.39;p = 0.86)或围产期死亡率(RR 0.81;95% ci 0.54-1.22;p = 0.32)。结论抗生素、吲哚美辛及其联用对环切术降低早产和围产期死亡风险无额外益处。
Antibiotics and indomethacin as perioperative management for cerclage: A systematic review and meta-analysis
Objective
Prematurity complications remain the leading cause of perinatal morbidity and mortality. Although cerclage shows promise in preventing preterm birth, it remains unclear whether perioperative management, such as the use of antibiotics or indomethacin, offers any additional benefit.
Study Desing
We conducted a systematic review and random-effects meta-analysis comparing the use of indomethacin, antibiotics, and their combination as perioperative management for cerclage versus cerclage alone. Our research protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO) on June 9, 2024 (ID CRD42024552516).
Results
Our systematic review encompassed ten studies, and 838 pregnant women submitted to cerclage for prevention of preterm birth. We found no association between perioperative management and preterm birth before 28 weeks (RR 1.03; 95 % CI 0.76–1.39; p = 0.86), or perinatal mortality (RR 0.81; 95 % CI 0.54–1.22; p = 0.32).
Conclusion
Antibiotics, indomethacin, and their combination may have no additional benefit to cerclage in risk reduction of preterm birth or perinatal mortality.
期刊介绍:
The European Journal of Obstetrics & Gynecology and Reproductive Biology is the leading general clinical journal covering the continent. It publishes peer reviewed original research articles, as well as a wide range of news, book reviews, biographical, historical and educational articles and a lively correspondence section. Fields covered include obstetrics, prenatal diagnosis, maternal-fetal medicine, perinatology, general gynecology, gynecologic oncology, uro-gynecology, reproductive medicine, infertility, reproductive endocrinology, sexual medicine and reproductive ethics. The European Journal of Obstetrics & Gynecology and Reproductive Biology provides a forum for scientific and clinical professional communication in obstetrics and gynecology throughout Europe and the world.